Get the Stockscreener App
2.57
22.38%
0.47
After Hours:
2.36
-0.21
-8.17%
Mangoceuticals Inc stock is traded at $2.57, with a volume of 129.54K.
It is up +22.38% in the last 24 hours and down -29.40% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$2.10
Open:
$2.12
24h Volume:
129.54K
Relative Volume:
0.81
Market Cap:
$9.41M
Revenue:
$755.00K
Net Income/Loss:
$-9.33M
P/E Ratio:
-0.4501
EPS:
-5.71
Net Cash Flow:
$-5.43M
1W Performance:
+63.69%
1M Performance:
-29.40%
6M Performance:
-3.02%
1Y Performance:
-39.24%
1-Day Range:
$2.12
$2.5725
1-Week Range:
$1.485
$2.5725
52-Week Range:
$1.485
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
2.57 | 9.41M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
215.95 | 36.39B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
53.21 | 9.87B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
40.45 | 7.46B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
84.52 | 7.21B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.45 | 6.30B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc Stock (MGRX) Latest News
Mangoceuticals Issues Bonus Shares to Leadership - MSN
Mangoceuticals (NASDAQ:MGRX) Trading Down 10.3% – Time to Sell? - Defense World
MGRX stock touches 52-week low at $1.79 amid market challenges By Investing.com - Investing.com South Africa
MGRX stock touches 52-week low at $1.79 amid market challenges - Investing.com Canada
Mangoceuticals issues new shares from preferred stock conversion - Investing.com India
Mangoceuticals issues new shares from preferred stock conversion By Investing.com - Investing.com South Africa
Mangoceuticals Inc (MGRX) Stock: Analyzing the Market Value - News Heater
Mangoceuticals Issues Common Stock in Exchange for Preferred - Investing.com Australia
Mangoceuticals Issues Common Stock in Exchange for Preferred By Investing.com - Investing.com South Africa
Mangoceuticals stock hits 52-week low at $2.06 - Investing.com India
Mangoceuticals stock hits 52-week low at $2.06 By Investing.com - Investing.com Australia
Mangoceuticals Inc (NASDAQ: MGRX) Stock: Bulls Should Watch This - Stocks Register
Mangoceuticals Expands into $33 Billion Addressable - GlobeNewswire
Mangoceuticals enters master distribution agreement for Diabetinol rights - TipRanks
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada - GlobeNewswire
Major Diabetes Market Breakthrough: Mangoceuticals Launches GLP-1 Alternative at Fraction of Cost - Stock Titan
Mangoceuticals Inc. (MGRX) reports earnings - Quartz
MANGOCEUTICALS, INC. SEC 10-K Report - TradingView
Mangoceuticals (NASDAQ:MGRX) Shares Up 18% – Time to Buy? - Defense World
Mangoceuticals Announces Equity and Leadership Changes By Investing.com - Investing.com Australia
Mangoceuticals, Inc. Approves Key Amendments at Special Meeting - TipRanks
Mangoceuticals Announces Equity and Leadership Changes - Investing.com
Mangoceuticals advances in H1N1 and H5N1 studies - MSN
Mangoceuticals, Inc. Now Featured on Webull Corporate Communications Service Platform - ACCESS Newswire
Shares of Healthcare Company Rise Following Product Availability Announcement - MSN
Mangoceuticals Launches PeachesRx, A Women's Telehealth Brand For Wellness And GLP-1 Treatments - Nasdaq
Mangoceuticals Announces the Launch of “PeachesRx”a - GlobeNewswire
Mangoceuticals rises on launch of women's telehealth brand - TradingView
Mangoceuticals launches PeachesRx women’s telehealth brand - TipRanks
This New Women's Health Platform Could Disrupt the $48B GLP-1 Weight Loss Market - StockTitan
Mangoceuticals Inc. issues stock for consulting services By Investing.com - Investing.com South Africa
Mangoceuticals Inc. issues stock for consulting services - Investing.com
Mangoceuticals (MGRX): A Low Float Stock on the Verge of a Short Squeeze? - Small Cap Exclusive
Mangoceuticals (NASDAQ:MGRX) versus Quipt Home Medical (NASDAQ:QIPT) Head to Head Analysis - Defense World
Mangoceuticals targets avian flu with water-based solution By Investing.com - Investing.com Nigeria
Mangoceuticals Advances Research on Avian Flu Treatment for Poultry Industry - Defense World
Mangoceuticals targets avian flu with water-based solution - MSN
Mangoceuticals, Inc. Advances Antiviral Research on its Patented Respiratory Illness Prevention Technology - Marketscreener.com
Mangoceuticals Advances Research On Avian Flu Solution For Poultry -February 12, 2025 at 08:19 am EST - Marketscreener.com
Mangoceuticals Advances Antiviral Research on its Patented - GlobeNewswire
Revolutionary Water-Based Solution Shows Promise in Fighting Bird Flu CrisisPhase I Results Reveal Major Breakthrough - StockTitan
Mangoceuticals Inc (MGRX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Mangoceuticals (NASDAQ: MGRX): A High-Growth Play With Multiple Catalysts - Small Cap Exclusive
Mangoceuticals Expands COO Role and Increases Compensation - TipRanks
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mangoceuticals Inc Stock (MGRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hamilton Alex P. | Director |
Jun 25 '24 |
Sale |
0.31 |
16,574 |
5,138 |
158,426 |
0.05%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):